| Peggy Lisa Mccullum, CNM | |
|
3640 Nw Samaritan Dr Ste 220, Corvallis, OR 97330-3784 | |
| (541) 768-5300 | |
| Not Available |
| Full Name | Peggy Lisa Mccullum |
|---|---|
| Gender | Female |
| Speciality | Midwife |
| Location | 3640 Nw Samaritan Dr Ste 220, Corvallis, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528005253 | NPI | - | NPPES |
| 200450148NP | Other | OR | STATE LICENSE |
| 200442216RN | Other | OR | STATE LICENSE |
| 269512 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 200450148NP (Oregon) | Secondary |
| 176B00000X | Midwife | 200450148NP (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Peggy Lisa Mccullum, CNM Po Box 1189, Corvallis, OR 97339-1189 Ph: () - | Peggy Lisa Mccullum, CNM 3640 Nw Samaritan Dr Ste 220, Corvallis, OR 97330-3784 Ph: (541) 768-5300 |
News Archive
Untreated depression in pregnant people is strongly linked to low birth weight and preterm birth, with Black pregnant people suffering worse outcomes than their white peers, according to a new meta-analysis led by Shannon Simonovich, assistant professor at DePaul University's School of Nursing.
Native Hawaiians, Hispanics, blacks and Japanese-Americans are significantly more likely than whites to be diagnosed with type 2 diabetes regardless of weight, even though the disease is closely linked with obesity, according to a recent study in Ethnicity and Disease, Reuters Health reports. The findings suggest that genetics might play a role in the development of type 2 diabetes.
SRU Biosystems has announced that U.S. Patent 7,070,987 (the '987 patent), entitled "Guided mode resonant filter biosensor using a linear grating surface structure" was issued to SRU Biosystems, Inc. on July 4, 2006.
An international team of scientists has rescued visual function in laboratory rats with eye disease by using cells similar to stem cells. The research shows the potential for stem cell-based therapies to treat age-related macular degeneration in humans.
Cryo-Cell International, Inc., one of the largest and most established leaders in stem cell innovation, today announced a research and development collaboration agreement with Monash University in Australia. The partnership will allow scientists from the University's Centre of Inflammatory Diseases to conduct pre-clinical studies using Cryo-Cell's proprietary C'elle menstrual stem cell technology (MenScs) to identify potential future therapies to treat autoimmune diseases such as multiple sclerosis.
› Verified 3 days ago